Xiaofei Zhou

9PUBLICATIONS
4CO-AUTHORS
Molecular targetsHaematological tumoursPharmacogenomicsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 17, 2025
A Phase 1 Study to Assess the Effect of Fruquintinib on the Pharmacokinetics of P-gp and BCRP Substrates in Healthy Subjects.

Martha Gonzalez, Zhao Yang, William R Schelman

|Jun 09, 2025
Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer.

Xiaofei Zhou, Alice Toms, Dave Morton

|Mar 17, 2025
Optimizing Brentuximab Vedotin Dosing in Pediatric Patients with Advanced Hodgkin Lymphoma: A Population Pharmacokinetic and Exposure-Response Analysis.

Xiaofei Zhou, Diane R Mould, Lia Gore

|Mar 13, 2025
Assessment of Food Effect and pH-Dependent Drug-Drug Interactions of Fruquintinib in Healthy Subjects.

Martha Gonzalez, Zhao Yang, William R Schelman

|Aug 26, 2021
Population Pharmacokinetics and Exposure-Safety Relationships of Alisertib in Children and Adolescents With Advanced Malignancies.

Xiaofei Zhou, Diane R Mould, Ying Yuan

|Oct 22, 2020
Phase I study assessing the mass balance, pharmacokinetics, and excretion of [14C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors.

Xiaofei Zhou, Farhad Sedarati, Douglas V Faller

Pageof 2

Frequent Collaborators

3 joint publications

Neeraj Gupta

2 joint publications

Diane R Mould

1 joint publications

Adekemi Taylor

1 joint publications

Caly Chien